CL2023002824A1 - Métodos y composiciones para tratar la apnea del sueño - Google Patents
Métodos y composiciones para tratar la apnea del sueñoInfo
- Publication number
- CL2023002824A1 CL2023002824A1 CL2023002824A CL2023002824A CL2023002824A1 CL 2023002824 A1 CL2023002824 A1 CL 2023002824A1 CL 2023002824 A CL2023002824 A CL 2023002824A CL 2023002824 A CL2023002824 A CL 2023002824A CL 2023002824 A1 CL2023002824 A1 CL 2023002824A1
- Authority
- CL
- Chile
- Prior art keywords
- methods
- sleep apnea
- compositions
- treat sleep
- antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163165342P | 2021-03-24 | 2021-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023002824A1 true CL2023002824A1 (es) | 2024-01-26 |
Family
ID=81388916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023002824A CL2023002824A1 (es) | 2021-03-24 | 2023-09-22 | Métodos y composiciones para tratar la apnea del sueño |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240173337A1 (https=) |
| EP (1) | EP4313153A1 (https=) |
| JP (1) | JP2024511091A (https=) |
| KR (1) | KR20230159462A (https=) |
| CN (1) | CN117062626A (https=) |
| AU (1) | AU2022245235A1 (https=) |
| BR (1) | BR112023019256A2 (https=) |
| CA (1) | CA3212035A1 (https=) |
| CL (1) | CL2023002824A1 (https=) |
| CO (1) | CO2023012587A2 (https=) |
| CR (1) | CR20230457A (https=) |
| GE (1) | GEAP202416361A (https=) |
| IL (1) | IL307186A (https=) |
| MX (1) | MX2023011213A (https=) |
| WO (1) | WO2022204228A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119789855A (zh) * | 2022-09-02 | 2025-04-08 | 爱普宁公司(特拉华) | 治疗睡眠呼吸暂停的方法和组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3746126B1 (en) * | 2018-01-30 | 2024-07-31 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea or simple snoring |
| EP4635514A3 (en) * | 2019-02-08 | 2025-12-24 | The Brigham & Women's Hospital, Inc. | Methods and compositions for treating sleep apnea |
| JP2023520455A (ja) * | 2020-04-02 | 2023-05-17 | アプニメッド，インコーポレイテッド（デラウェア） | 睡眠時無呼吸を治療するための方法および組成物 |
-
2022
- 2022-03-23 GE GEAP202416361A patent/GEAP202416361A/en unknown
- 2022-03-23 CR CR20230457A patent/CR20230457A/es unknown
- 2022-03-23 CA CA3212035A patent/CA3212035A1/en active Pending
- 2022-03-23 EP EP22719398.4A patent/EP4313153A1/en active Pending
- 2022-03-23 CN CN202280024023.9A patent/CN117062626A/zh active Pending
- 2022-03-23 BR BR112023019256A patent/BR112023019256A2/pt unknown
- 2022-03-23 KR KR1020237034335A patent/KR20230159462A/ko active Pending
- 2022-03-23 US US18/283,303 patent/US20240173337A1/en active Pending
- 2022-03-23 AU AU2022245235A patent/AU2022245235A1/en active Pending
- 2022-03-23 IL IL307186A patent/IL307186A/en unknown
- 2022-03-23 WO PCT/US2022/021462 patent/WO2022204228A1/en not_active Ceased
- 2022-03-23 MX MX2023011213A patent/MX2023011213A/es unknown
- 2022-03-23 JP JP2023558248A patent/JP2024511091A/ja active Pending
-
2023
- 2023-09-22 CL CL2023002824A patent/CL2023002824A1/es unknown
- 2023-09-22 CO CONC2023/0012587A patent/CO2023012587A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023019256A2 (pt) | 2023-10-17 |
| CA3212035A1 (en) | 2022-09-29 |
| WO2022204228A1 (en) | 2022-09-29 |
| KR20230159462A (ko) | 2023-11-21 |
| JP2024511091A (ja) | 2024-03-12 |
| CR20230457A (es) | 2024-02-19 |
| CN117062626A (zh) | 2023-11-14 |
| CO2023012587A2 (es) | 2023-10-19 |
| MX2023011213A (es) | 2023-10-02 |
| AU2022245235A1 (en) | 2023-10-12 |
| EP4313153A1 (en) | 2024-02-07 |
| GEAP202416361A (en) | 2024-04-25 |
| US20240173337A1 (en) | 2024-05-30 |
| IL307186A (en) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEAP202115226A (en) | Methods and compositions for treating sleep apnea | |
| ECSP22091485A (es) | Imidazolpiridazinas como moduladores de il-17 | |
| MX2024001713A (es) | Metodos y composiciones para tratar la apnea del sue?o. | |
| CY1121675T1 (el) | Διαμορφωτες υποδοχεων nmdα σπeipο-λακταμης και χρησεις αυτων | |
| CL2018001996A1 (es) | Composiciones y métodos para modular la expresión del factor b del complemento (divisional de solicitud 2764-16) | |
| BR112014027860B8 (pt) | Moduladores do transporte nuclear e usos dos mesmos | |
| SA521421595B1 (ar) | تركيبات وطرق لعلاج اضطرابات محسنة بتنشيط مستقبل مسكاريني | |
| BR112017014067A2 (pt) | composição para tratar doenças relacionadas a il-6 | |
| CO6390117A2 (es) | Regimen de dosificación para un agonista de los receptores de s1p | |
| MX366197B (es) | Metodo de monitoreo terapeutico de farmacos depuradores de nitrogeno. | |
| CO7310528A2 (es) | Composición farmacéutica recubierta que contiene regorafenib | |
| CO2024003723A2 (es) | Compuestos de imidazopiridazina inhibidores de il-17 | |
| MX2022006176A (es) | Terapia combinada que comprende un inhibidor de alk2 y un inhibidor de jak2. | |
| MX2019003373A (es) | Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos. | |
| BR112017026272A2 (pt) | ?composto, composição farmacêutica, método para o tratamento de uma desordem relacionada a receptor m1 muscarínico e uso do composto? | |
| CL2023002824A1 (es) | Métodos y composiciones para tratar la apnea del sueño | |
| UY33529A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias? | |
| BR112018004719A2 (pt) | composto de fluoroindola, composição farmacêutica, método para o tratamento de uma desordem relacionada a receptor muscarínico m1 e uso do composto | |
| MX2021009488A (es) | Uso de vibegron para tratar la vejiga hiperactiva. | |
| UA107660C2 (ru) | Антагонисты арилсульфонамидов ccr3 | |
| BR112018073419A2 (pt) | combinação, uso da combinação, método para o tratamento, composto, método para o tratamento de doença de alzheimer e composição farmacêutica | |
| CL2008003558A1 (es) | Composicion farmaceutica que comprende valrubicina y sulfoxido de dimetilo en forma de dosis intravesical, util para tratar cancer a la vejiga. | |
| BR112015001524A2 (pt) | composto, processo para a preparação de um composto, composição farmacêutica, método para o tratamento de déficits cognitivos e uso de um composto | |
| BR112018073396A2 (pt) | combinação de antagonistas, uso de uma combinação, método para o tratamento de desordens cognitivas, composto, método para o tratamento de doença de alzheimer e composição farmacêutica | |
| BR112022013160A2 (pt) | Dextrometadona como tratamento modificador de doença para transtornos e doenças neuropsiquiátricos |